661 related articles for article (PubMed ID: 17206080)
21. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
22. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
[TBL] [Abstract][Full Text] [Related]
23. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
24. CARD15 gene variants and risk of reoperation in Crohn's disease patients.
Maconi G; Colombo E; Sampietro GM; Lamboglia F; D'Incà R; Daperno M; Cassinotti A; Sturniolo GC; Ardizzone S; Duca P; Porro GB; Annese V
Am J Gastroenterol; 2009 Oct; 104(10):2483-91. PubMed ID: 19638967
[TBL] [Abstract][Full Text] [Related]
25. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
27. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
Lashner BA; Shaheen NJ; Hanauer SB; Kirschner BS
Am J Gastroenterol; 1993 Mar; 88(3):356-9. PubMed ID: 8438840
[TBL] [Abstract][Full Text] [Related]
28. Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease.
Onnie CM; Fisher SA; Prescott NJ; Mirza MM; Green P; Sanderson J; Forbes A; Lewis CM; Mathew CG
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):37-45. PubMed ID: 18090989
[TBL] [Abstract][Full Text] [Related]
29. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
Barreiro-de Acosta M; Peña AS
Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
[TBL] [Abstract][Full Text] [Related]
30. Gender-related differences in the clinical course of Crohn's disease.
Wagtmans MJ; Verspaget HW; Lamers CB; van Hogezand RA
Am J Gastroenterol; 2001 May; 96(5):1541-6. PubMed ID: 11374696
[TBL] [Abstract][Full Text] [Related]
31. Cigarette smoking in Crohn's disease.
Silverstein MD; Lashner BA; Hanauer SB; Evans AA; Kirsner JB
Am J Gastroenterol; 1989 Jan; 84(1):31-3. PubMed ID: 2912028
[TBL] [Abstract][Full Text] [Related]
32. Clinical manifestations of inflammatory bowel disease: East and West differences.
Wang YF; Zhang H; Ouyang Q
J Dig Dis; 2007 Aug; 8(3):121-7. PubMed ID: 17650222
[TBL] [Abstract][Full Text] [Related]
33. Colonic lymphoid follicles and NOD2/CARD15 mutational status in Crohn's disease.
Nascimbeni R; Villanacci V; Bassotti G; Fisogni S; Gervasi M; Rossi E; Di Lorenzo D
Br J Surg; 2009 Jun; 96(6):655-62. PubMed ID: 19434699
[TBL] [Abstract][Full Text] [Related]
34. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
[TBL] [Abstract][Full Text] [Related]
35. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease.
Chua KH; Hilmi I; Ng CC; Eng TL; Palaniappan S; Lee WS; Goh KL
J Dig Dis; 2009 May; 10(2):124-30. PubMed ID: 19426395
[TBL] [Abstract][Full Text] [Related]
36. A functional interleukin-10 mutation in Dutch patients with Crohn's disease.
van der Linde K; Boor PP; van Bodegraven AA; de Jong DJ; Crusius JB; Naber TH; Kuipers EJ; Wilson JH; de Rooij FW
Dig Liver Dis; 2005 May; 37(5):330-5. PubMed ID: 15843082
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting recurrence in patients with Crohn's disease under nutritional therapy.
Esaki M; Matsumoto T; Nakamura S; Yada S; Fujisawa K; Jo Y; Iida M
Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S68-74. PubMed ID: 17106818
[TBL] [Abstract][Full Text] [Related]
38. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
40. Clinical and genetic factors associated with sacroiliitis in Crohn's disease.
Peeters H; Vander Cruyssen B; Mielants H; de Vlam K; Vermeire S; Louis E; Rutgeerts P; Belaiche J; De Vos M
J Gastroenterol Hepatol; 2008 Jan; 23(1):132-7. PubMed ID: 17725592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
